Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disruption of MerTK increases the efficacy of checkpoint inhibitor by enhancing ferroptosis and immune response in hepatocellular carcinoma
Shun Wang, Zhu Le, Tianen Li, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101415-101415
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Ferroptosis: mechanisms and therapeutic targets
Qian Zhou, Yu Meng, Jiayuan Le, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 9
Advances in Ferroptosis Research: A Comprehensive Review of Mechanism Exploration, Drug Development, and Disease Treatment
Haojie Wang, Yuanyuan Xie
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 334-334
Open Access | Times Cited: 1
Ferroptosis crosstalk in anti-tumor immunotherapy: molecular mechanisms, tumor microenvironment, application prospects
Y. F. Lu, Xiao‐Ting Xie, Lianxiang Luo
APOPTOSIS (2024) Vol. 29, Iss. 11-12, pp. 1914-1943
Closed Access | Times Cited: 7
Cold atmospheric plasma enhances SLC7A11-mediated ferroptosis in non-small cell lung cancer by regulating PCAF mediated HOXB9 acetylation
Chenxing Zhang, Hongyang Liu, X. Li, et al.
Redox Biology (2024) Vol. 75, pp. 103299-103299
Open Access | Times Cited: 5
Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Spatial heterogeneity of the hepatocellular carcinoma microenvironment determines the efficacy of immunotherapy
Minni Zhang, Kai‐Lin Huang, Qiushi Yin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs
Cunzhen Zhang, Jiyao Wang, Lin Jia, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 236-236
Open Access
Rational Design of Single‐Atom Nanozymes for Combination Cancer Immunotherapy
Hanchao Lin, Yonghui Gao, Le Zhu, et al.
Advanced Functional Materials (2025)
Closed Access
SLC7A11 is a potential therapeutic target and prognostic biomarker correlated with immune cell infiltration in cervical cancer
Mutangala Muloye Guy, Tingting Bian, Lingwei Sun, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Dicoumarol sensitizes hepatocellular carcinoma cells to ferroptosis induced by imidazole ketone erastin
Ziwei Yang, Tixin Han, Ruibin Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Comprehensive network pharmacology and experimental study to investigate the effect and mechanism of solasonine on breast carcinoma treatment
Wenkai Ge, Min Gao, Yingqi Dai, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma
Yizhe Zhang, Yunshu Ma, Ensi Ma, et al.
Cancer Drug Resistance (2025)
Open Access
Multidimensional applications of prussian blue-based nanoparticles in cancer immunotherapy
Jiayi Zhang, Fang Wang, Zhaogang Sun, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
Diana Llópiz, Leyre Silva, Marta Ruiz, et al.
OncoImmunology (2025) Vol. 14, Iss. 1
Open Access
The immunosuppressive role of MDSCs in HCC: mechanisms and therapeutic opportunities
Xiling Liu, Xichun Kang, Haiyan Kang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Dual-responsive magnetic vortex nanorings co-deliver lenvatinib and localized heat for synergistic activation of antitumor immunity
Zirui Ye, Bin Yan, Hugang Li, et al.
Acta Biomaterialia (2025)
Closed Access
The NET-DNA-CCDC25 inhibitor di-Pal-MTO suppresses tumor progression and promotes the innate immune response
Shun Wang, Xinyan Liang, Heliang Li, et al.
Cellular and Molecular Immunology (2025)
Closed Access
The important role of myeloid-derived suppressor cells: From hepatitis to liver cancer
Siwen Li, Jiaqian Zhang, Wei Wang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189329-189329
Open Access
Copper-mediated SEC14L3 promotes cuproptosis to inhibit hepatocellular carcinoma growth via ERK/YY1/FDX1 axis
Chutian Wu, Linjing Long, Min Wang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Anti-tumor effect and immune-related mechanism study of compound aluminum sulfate injection in transplanted tumor-bearing mice
Zhenwei Shi, Zhifa Xia, Songtao Huang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Sorafenib-induced macrophage extracellular traps via ARHGDIG/IL4/PADI4 axis confer drug resistance through inhibiting ferroptosis in hepatocellular carcinoma
Xiangbo Huang, Nan Yi, Pengfei Zhu, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Ferroptosis: insight into the treatment of hepatocellular carcinoma
Chuanjie Liao, Youwu He, Xingju Luo, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
IGF2BP1 Bolsters the Chondrocytes Ferroptosis of Osteoarthritis by Targeting m6A/MMP3 Axis
Ziqin Zhao, Shuhui Dong, Yong Yang, et al.
International Journal of General Medicine (2024) Vol. Volume 17, pp. 2433-2443
Open Access | Times Cited: 2
CAV1 inhibits Xc- system through IFNGR1 to promote ferroptosis to inhibit stemness and improves anti-PD-1 efficacy in breast cancer
Wenhong Liu, Guanghua Luo
Translational Oncology (2024) Vol. 50, pp. 102149-102149
Open Access
Page 1 - Next Page

Scroll to top